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A 28-year-old woman presented with a painless tumour on 
her upper lip (Fig. 1). She had no medical history and used 
no medications. The tumour had been present since early 
childhood and had so far been considered benign. Over the 
last 5 years the tumour had grown slowly, and therefore the 
patient was referred for dermatological evaluation. On exa-
mination, the tumour was 1.5 cm in diameter, well-defined, 
circular, with marked induration, and non-adherent to the 
surroundings. The skin covering the tumour was unremark-
able apart from mild redness and minor telangiectasia at 
the periphery. The patient was otherwise asymptomatic and 
had no palpable lymph nodes. 
What is your diagnosis? See next page for answer.
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Fig. 1. Clinical presentation. Arrow indicates tumour location. The central 
papule represents a cicatrice after the first biopsy.
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Diagnosis: Microcystic adnexal carcinoma
Two 3-mm punch biopsies were performed. The biopsies 
showed a diffusely infiltrative dermal tumour composed of 
narrow basaloid epithelial strands with focal duct formation 
in the upper dermis. There was slight cellular atypia. Immu-
nohistochemistry showed positive staining for CK5, CK15, 
CK19, p40, and CD10, as well as weakly positive staining 
for CK7 and EMA luminally in the duct-like structures. 
Staining for Ep4, androgen receptor, CK20, Sox10, Mel-
anA, and S-100 were negative. Consequently, a diagnosis 
of microcystic adnexal carcinoma (MAC) was suspected, 
along with desmoplastic trichoepithelioma and syringoma. 
A deeper knife biopsy was performed to assess the border 
of the tumour and the peripheral pattern of growth. The 
punch biopsy specimens were compared with the knife 
biopsy specimen, which showed the same morphology 
and immunohistochemical staining pattern. Furthermore, 
muscular invasion and possible perineural invasion (Fig. 
2) was found in the deeper biopsy. Therefore, desmoplastic 
trichoepithelioma and syringoma were excluded and the 
diagnosis of MAC was confirmed.
A preoperative positron-emission tomography – com-
puted tomography (PET-CT) scan revealed multiple me-
tabolically active lymph nodes on the neck, including one 
enlarged lymph node. Ultrasound guided biopsy of the 
enlarged lymph node showed no metastasis. The MAC 
tumour was excised with a 3-mm clinical margin, leaving 
part of the orbicularis muscle intact, and 2 sentinel lymph 
nodes were removed, both without metastases. Additional 
muscle tissue had to be excised from 2 small areas because 
the primary deep margin was only partially clear. Follo-
wing granulation, the defect was reconstructed with a full 
thickness skin graft. 
MAC is a malignant adnexal tumour, probably deriving 
from a pluripotent adnexal keratinocyte. MAC is a rare con-
dition with a reported incidence of 1.6–6.5 per 10,000,000 
individuals (1). It occurs at all ages, but the reported mean 
age of incidence ranges between 44 and 64 years (2, 3). 
Predisposing factors may exist (2, 4, 5). 
MAC has a predilection for the head and neck. Upon 
diagnosis, it has often been present for years. The lesion 
may be yellowish or skin-coloured, possibly with overlying 
telangiectasia. Typically, the surface is inconspicuous. The 
tumour is indurated, but asymptomatic. In some cases, pain, 
burning, paraesthesia, and anaesthesia have been reported 
(6, 7).
MAC is an indolent tumour with slow growth. None-
theless, it is locally aggressive and early on invades local 
structures and deep tissue (8, 9). Only rare reports of lymph 
node metastases exist (2, 6, 10, 11). There is a significant 
risk of recurrence, possibly due to a high propensity for pe-
rineural invasion. In fact, local recurrence has been reported 
30 years after primary treatment (12).
Importantly, the diagnosis may be challenging. Indeed, 
initial histopathological misdiagnosis was reported to 
range from 27% to 69% of cases (7, 13). This may be due 
to similar histopathological findings in MAC and other 
locally aggressive adnexal tumours, especially syringoma, 
desmoplastic trichoepithelioma, or infiltrative basal cell 
carcinoma (7, 13). Moreover, unique immunohistochemical 
markers to distinguish MAC from its differential diagnoses 
have not been identified and, as in the current case, a deep 
biopsy is valuable in identifying perineural or muscular 
infiltration (7, 13).
Characteristically, MAC extends far beyond the clinical 
margin. Hence, local recurrence has been reported to occur 
in 40–60% of patients after standard wide excision (13). 
Consequently, histological verification of clear margins is 
imperative and Mohs micrographic surgery has been pro-
posed as the optimal treatment. Radiation therapy remains 
controversial (7). 
In summary, the present case emphasizes the difficulty of 
correctly diagnosing MAC on superficial sections. Without 
an appropriately deep biopsy, MAC can progress unnoticed, 
delaying diagnosis and impeding proper treatment. Further-
more, the need to confirm free margins upon surgery, as well 
as long-term follow-up, must be emphasized. 
REFERENCES 
1. Yu Y, Finn DT, Rogers GS. Microcystic adnexal carcinoma: a 
rare, locally aggressive cutaneous tumor. Am J Clin Oncol 
2010; 33: 196–197.
2. Carroll P, Goldstein GD, Brown CW, Jr. Metastatic microcys-
tic adnexal carcinoma in an immunocompromised patient. 
Dermatol Surg 2000; 26: 531–534.
3. Page RN, Hanggi MC, King R, Googe PB. Multiple microcystic 
adnexal carcinomas. Cutis 2007; 79: 299–303.
4. Friedman PM, Friedman RH, Jiang SB, Nouri K, Amonette R, 
Robins P. Microcystic adnexal carcinoma: collaborative series 
review and update. J Am Acad Dermatol 1999; 41: 225–231.
5. Khachemoune A, Olbricht SM, Johnson DS. Microcystic adnexal 
carcinoma: report of four cases treated with Mohs’ micrograp-
hic surgical technique. Int J Dermatol 2005; 44: 507–512.
Fig. 2. (A) The dermis is expanded by tumour tissue (haematoxylin and 
eosin (H&E) ×2.5). (B) A tumour islet (arrow) located immediately next 
to a small nerve fibre (stars) (H&E ×20).
A
ct
aD
V
A
ct
aD
V
A
d
v
a
n
c
e
s 
in
 d
e
rm
a
to
lo
g
y
 a
n
d
 v
e
n
e
re
o
lo
g
y
A
c
ta
 D
e
rm
a
to
-V
e
n
e
re
o
lo
g
ic
a
Quiz: Diagnosis 1321
Acta Derm Venereol 2019
6. Bier-Laning CM, Hom DB, Gapany M, Manivel JC, Duvall AJ, 
3rd. Microcystic adnexal carcinoma: management options 
based on long-term follow-up. Laryngoscope 1995; 105: 
1197–1201.
7. Gordon S, Fischer C, Martin A, Rosman IS, Council ML. 
Microcystic adnexal carcinoma: a review of the literature. 
Dermatol Surg 2017; 43: 1012–1016.
8. Leibovitch I, Huilgol SC, Selva D, Lun K, Richards S, Paver R. 
Microcystic adnexal carcinoma: treatment with Mohs micro-
graphic surgery. J Am Acad Dermatol 2005; 52: 295–300.
9. Palamaras I, McKenna JD, Robson A, Barlow RJ. Microcystic 
adnexal carcinoma: a case series treated with mohs mi-
crographic surgery and identification of patients in whom 
paraffin sections may be preferable. Dermatol Surg 2010; 
36: 446–452.
10. Ban M, Sugie S, Kamiya H, Kitajima Y. Microcystic adnexal 
carcinoma with lymph node metastasis. Dermatology 2003; 
207: 395–397.
11. Yugueros P, Kane WJ, Goellner JR. Sweat gland carcinoma: 
a clinicopathologic analysis of an expanded series in a single 
institution. Plast Reconstr Surg 1998; 102: 705–710.
12. Lupton GP, McMarlin SL. Microcystic adnexal carcinoma. Re-
port of a case with 30-year follow-up. Arch Dermatol 1986; 
122: 286–289.
13. Mamic M, Manojlovic L, Suton P, Luksic I. Microcystic adnexal 
carcinoma-diagnostic criteria and therapeutic methods: case 
report and review of the literature. Int J Oral Maxillofac Surg 
2018; 47: 1258–1262.
